NexAir sees demand rise for dry ice, no thanks to Pfizer vaccine
NexAir expected a surge in its sales of dry ice to ship and store Pfizer’s COVID-19 vaccine. That never happened. But the company still forecasts a 16% increase in dry ice sales this year because of the growing demands of e-commerce.
Topics
nexAir Manufacturing pfizer vaccineTom Bailey
Tom Bailey retired in January as a business reporter at The Daily Memphian, and after 40 years in journalism. A Tupelo, Mississippi, native, he graduated from Mississippi State University. He has lived in Midtown for 36 years.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.